Skip to main content
Premium Trial:

Request an Annual Quote

Thermo To Lay Off 100 Employees in Massachusetts Plant Closing

NEW YORK, May 1 (GenomeWeb News) - Thermo Electron plans to "discontinue all manufacturing and distribution operations" at its Milford, Mass., facility, the company disclosed in a filing with the US Securities and Exchange Commission on Friday.


As a result, Thermo said it will lay off 100 employees.


The facility is part of Thermo's Life and Laboratory Sciences segment and primarily manufactures centrifuges, molecular biology products, vacuum concentrators, and power supplies.


The Milford plant's activities will be relocated to Thermo's facility in Asheville, NC, which it acquired as part of its Kendro acquisition last May.


Thermo said in the SEC filing that it expects restructuring charges associated with the plant closing of around $8 million, including $2.3 million of severance and related personnel costs and $3.2 million of abandoned facility costs.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.